11/21
08:08 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
11/21
08:08 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
11/20
08:07 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
11/20
04:39 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/20
04:39 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/18
08:07 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
11/8
06:44 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/8
06:44 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/7
04:11 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
10/18
08:33 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
10/18
07:58 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
10/17
08:55 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
10/17
08:55 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
10/17
05:38 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
10/17
05:38 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
9/30
08:01 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
9/20
08:12 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
9/9
01:03 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
9/9
12:59 pm
cytk
Rating for CYTK
Low
Report
Rating for CYTK
9/9
08:08 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
9/5
11:58 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
9/4
01:12 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $78.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $78.00 price target on the stock.
9/4
01:12 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $78.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $78.00 price target on the stock.
9/4
12:16 pm
cytk
Rating for CYTK
Low
Report
Rating for CYTK
9/4
12:16 pm
cytk
Rating for CYTK
Low
Report
Rating for CYTK